Literature DB >> 6425892

Effects of scopolamine and nicotine on human rapid information processing performance.

K Wesnes, D M Warburton.   

Abstract

In the first experiment, after a 10-min baseline test on a rapid information processing task, subjects received oral doses of either placebo, methscopolamine 1.2 mg, scopolamine 0.6 mg or scopolamine 1.2 mg, and 1 h later performed the task again for a 20-min period. Following scopolamine 1.2 mg, correct detections were significantly lower over the 20-min period, whereas no such decrement was observed in the other three conditions. In the second experiment a similar design was used to study the effects of nicotine 0.5 mg, 1.0 mg and 1.5 mg and placebo, except that post-drug testing was carried out 10 min after baseline due to the faster absorption of nicotine. Nicotine helped prevent both the decline in detections and the increase in reaction time which occurred over time in the placebo condition. These findings indicate that compounds with opposite effects on central cholinergic pathways produce opposite effects on the performance of a task involving rapid information processing, and are consistent with previous findings from this laboratory.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6425892     DOI: 10.1007/bf00427761

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  9 in total

1.  The facilitation of discrimination performance by physostigmine sulphate.

Authors:  D M Warburton; K Brown
Journal:  Psychopharmacologia       Date:  1972

2.  Differential actions of m and n cholinergic agonitst on the brainstem activating system.

Authors:  H Kawamura; E F Domino
Journal:  Int J Neuropharmacol       Date:  1969-03

Review 3.  Neurochemistry of behaviour.

Authors:  D M Warburton
Journal:  Br Med Bull       Date:  1981-05       Impact factor: 4.291

4.  Effects of smoking on rapid information processing performance.

Authors:  K Wesnes; D M Warburton
Journal:  Neuropsychobiology       Date:  1983       Impact factor: 2.328

Review 5.  Smoking, nicotine and human performance.

Authors:  K Wesnes; D M Warburton
Journal:  Pharmacol Ther       Date:  1983       Impact factor: 12.310

6.  Effects of nicotine on stimulus sensitivity and response bias in a visual vigilance task.

Authors:  K Wesnes; D M Warburton; B Matz
Journal:  Neuropsychobiology       Date:  1983       Impact factor: 2.328

7.  Central and peripheral effects of muscarinic cholinergic blocking agents in man.

Authors:  E F Domino; G Corssen
Journal:  Anesthesiology       Date:  1967 May-Jun       Impact factor: 7.892

8.  Effects of scopolamine on stimulus sensitivity and response bias in a visual vigilance task.

Authors:  K Wesnes; D M Warburton
Journal:  Neuropsychobiology       Date:  1983       Impact factor: 2.328

9.  An analysis of the learning deficit following hyoscine administration to man.

Authors:  T J Crow; I G Grove-White
Journal:  Br J Pharmacol       Date:  1973-10       Impact factor: 8.739

  9 in total
  86 in total

1.  Landmark publications in Psychopharmacology: the first 40 years.

Authors:  K A Miczek
Journal:  Psychopharmacology (Berl)       Date:  2001-02       Impact factor: 4.530

2.  Commentary on: "comprehensive observational assessment: Ia. A systematic, quantitative procedure for assessing the behavioral and physiologic state of the mouse." Psychopharmacologia (1968) 13: 222-257.

Authors:  David M Warburton
Journal:  Psychopharmacology (Berl)       Date:  2002-08       Impact factor: 4.530

3.  Psychomotor performance in smokers following single and repeated doses of nicotine gum.

Authors:  N Sherwood; J S Kerr; I Hindmarch
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

4.  Enhancement of continuous performance task reaction time by smoking in non-deprived smokers.

Authors:  W S Pritchard; J H Robinson; T D Guy
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

5.  The nicotinic acetylcholine receptor alpha5 subunit plays a key role in attention circuitry and accuracy.

Authors:  Craig D C Bailey; Mariella De Biasi; Paul J Fletcher; Evelyn K Lambe
Journal:  J Neurosci       Date:  2010-07-07       Impact factor: 6.167

Review 6.  Measuring nicotine dependence: a review of the Fagerstrom Tolerance Questionnaire.

Authors:  K O Fagerstrom; N G Schneider
Journal:  J Behav Med       Date:  1989-04

7.  Caffeine and nicotine improve visual tracking by rats: a comparison with amphetamine, cocaine and apomorphine.

Authors:  J L Evenden; M Turpin; L Oliver; C Jennings
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

8.  Absence of central functional cholinergic deficits in myasthenia gravis.

Authors:  S W Lewis; M A Ron; J Newsom-Davis
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-02       Impact factor: 10.154

9.  Performance effects of nicotine during selective attention, divided attention, and simple stimulus detection: an fMRI study.

Authors:  Britta Hahn; Thomas J Ross; Frank A Wolkenberg; Diaa M Shakleya; Marilyn A Huestis; Elliot A Stein
Journal:  Cereb Cortex       Date:  2008-12-10       Impact factor: 5.357

10.  Reversal of visual attentional dysfunction following lesions of the cholinergic basal forebrain by physostigmine and nicotine but not by the 5-HT3 receptor antagonist, ondansetron.

Authors:  J L Muir; B J Everitt; T W Robbins
Journal:  Psychopharmacology (Berl)       Date:  1995-03       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.